Help:WikiPathways Portals
From WikiPathways
(Difference between revisions)
| Line 23: | Line 23: | ||
* [[Portal:AOP|Adverse Outcome Pathway]] | * [[Portal:AOP|Adverse Outcome Pathway]] | ||
| - | * [[Portal: | + | * [[Portal:IEM|Inborn Errors of Metabolism (IEM)]] |
* [[Portal:CIRM|California Institute for Regenerative Medicine, CIRM]] | * [[Portal:CIRM|California Institute for Regenerative Medicine, CIRM]] | ||
* [[Portal:Disease/COVIDPathways|COVID-19]] | * [[Portal:Disease/COVIDPathways|COVID-19]] | ||
Revision as of 18:26, 15 September 2020
Community Featured Pathways IEMUnable to get pathway of the day: There are no pathways tagged with 'Curation:Blau'! |
Community Featured Pathways COVID-19Soluble ACE2-mediated cell entry of SARS-CoV-2 (Homo sapiens) Image does not exist Soluble ACE2-mediated cell entry of SARS-CoV-2 |
Portals within WikiPathways serve as organizing points for communities with focused pathway interests. For example, a portal could organize pathways for a particular species or research area.
The main advantages of portals include:
- Simplified drawing and collecting your pathways
- Help to keep track of ‘works-in-progress’ with collaborators
- Help attribute credit for pathway authors and curators
- Attract new collaborators
- Help to define a community
Creating a portal is easy using existing templates available from WikiPathways.
If you are interested, please consult the portal maintenance guide and contact us for assistance.
WikiPathways has a growing list of portals:
- Adverse Outcome Pathway
- Inborn Errors of Metabolism (IEM)
- California Institute for Regenerative Medicine, CIRM
- COVID-19
- Clinical Proteomic Tumor Analysis Consortium, CPTAC
- Disease
- ExRNA
- Lipids
- Micronutrients
- Nanomaterials
- NetPath
- Plant Pathways
- Rare Disease
- Renal Genomics
- Reactome
- Skeletal Dysplasia
- WormBase
